Fang Cao Selected Research

COG1410

1/2017	Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An 18F-Fluorodeoxyglucose PET/CT Study.
1/2016	Apolipoprotein E-Mimetic COG1410 Reduces Acute Vasogenic Edema following Traumatic Brain Injury.
1/2016	An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fang Cao Research Topics

Disease

29	Neoplasms (Cancer) 03/2022 - 05/2008
9	Breast Neoplasms (Breast Cancer) 03/2021 - 05/2008
9	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2016
8	Glioma (Gliomas) 09/2021 - 01/2017
8	Carcinogenesis 04/2021 - 05/2008
5	COVID-19 01/2022 - 06/2020
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019 - 01/2016
5	Brain Injuries (Brain Injury) 08/2016 - 03/2011
4	Infections 11/2020 - 09/2013
4	Pneumonia (Pneumonitis) 04/2020 - 01/2015
4	Inflammation (Inflammations) 01/2020 - 01/2017
4	Neuroinflammatory Diseases 01/2020 - 01/2016
4	Brain Ischemia (Cerebral Ischemia) 01/2016 - 05/2009
3	Necrosis 10/2022 - 01/2021
3	Adenocarcinoma 09/2022 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 03/2021 - 01/2015
3	Osteonecrosis (Kienbock's Disease) 11/2020 - 01/2017
3	Stroke (Strokes) 05/2020 - 03/2011
3	Brain Edema (Cerebral Edema) 01/2020 - 03/2016
3	Cerebral Hemorrhage 01/2020 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2012
3	Leukemia 01/2017 - 01/2013
2	Thrombosis (Thrombus) 04/2022 - 11/2020
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2016
2	Femoral Neck Fractures 01/2021 - 01/2020
2	Infarction (Infarctions) 01/2020 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 02/2018 - 02/2017
2	Wounds and Injuries (Trauma) 01/2017 - 06/2007
2	Hypoxia (Hypoxemia) 01/2017 - 06/2007
2	Schizophrenia (Dementia Praecox) 05/2013 - 08/2012
2	Ischemia 10/2012 - 05/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022
1	Cholangiocarcinoma 03/2022
1	Hematuria 01/2022
1	Atrophy 01/2022
1	Segmental glomerulosclerosis 01/2022
1	Proteinuria 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Sciatica (Sciatic Neuralgia) 02/2021

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2008
10	Messenger RNA (mRNA)IBA 01/2021 - 06/2007
8	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 03/2021 - 08/2012
6	Pharmaceutical PreparationsIBA 07/2020 - 01/2018
6	ApolipoproteinsIBA 01/2020 - 01/2016
5	Long Noncoding RNAIBA 03/2021 - 01/2016
5	CytokinesIBA 01/2020 - 01/2015
4	Neuroprotective AgentsIBA 05/2017 - 01/2016
3	InterferonsIBA 01/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2018
3	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2013
3	Peptides (Polypeptides)IBA 12/2019 - 01/2016
3	MethyltransferasesIBA 01/2017 - 01/2013
3	COG1410IBA 01/2017 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2015
3	Biological ProductsIBA 01/2016 - 12/2015
2	SteroidsIBA 10/2022 - 01/2017
2	CateninsIBA 01/2021 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2021
2	AlbuminsIBA 11/2020 - 08/2018
2	CalciumIBA 08/2020 - 12/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2018
2	Therapeutic UsesIBA 08/2019 - 01/2015
2	Tamoxifen FDA LinkGeneric 01/2019 - 01/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2018 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 02/2018 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Complement System Proteins (Complement)IBA 03/2017 - 03/2016
2	ORALIT (ORS)IBA 02/2017 - 01/2016
2	MM-401IBA 01/2017 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 06/2007
2	Protein Isoforms (Isoforms)IBA 01/2017 - 05/2013
2	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2015
2	Bexarotene (LGD1069)FDA Link 01/2017 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2017
2	Apolipoproteins E (ApoE)IBA 08/2016 - 01/2016
2	Evans Blue (Blue, Evans)FDA Link 03/2016 - 01/2016
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	human ERBB2 proteinIBA 07/2022
1	licochalcone AIBA 03/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	SootIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	gallium Ga 68 dotatateIBA 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	CholesterolIBA 01/2022
1	somatostatin receptor 2IBA 01/2022
1	InflammasomesIBA 09/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2021
1	Phosphotransferases (Kinase)IBA 04/2021

Therapy/Procedure

16	Therapeutics 09/2022 - 10/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2004
3	Immunotherapy 01/2021 - 01/2020
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2020 - 03/2018
1	Renal Dialysis (Hemodialysis) 04/2022
1	Hematopoietic Stem Cell Transplantation 12/2021